Evidence map›Paper›PMID 40366391›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2025

Initial [

Lin Chen, Jing Wang, Chentao Jin, Congcong Yu, Yan Zhong, Xiaofeng Dou, Xiaohui Zhang, Piaopiao Zhang, Juan Chen, Jingyu Chen and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lin Chen *Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Jing Wang *Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Chentao Jin *Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Congcong Yu *Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Yan ZhongDepartment of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Xiaofeng DouDepartment of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Xiaohui ZhangDepartment of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Piaopiao ZhangDepartment of Lung Transplantation, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Juan ChenDepartment of General Intensive Care Unit, The Second Affiliated Hospital of Zhejiang, University School of Medicine, Hangzhou, Zhejiang, China.
Jingyu ChenDepartment of Lung Transplantation, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. chenjy9611@zju.edu.cn.
Mei TianHuman Phenome Institute, Fudan University, Shanghai, China. tianmei@fudan.edu.cn.
Hong ZhangDepartment of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. hzhang21@zju.edu.cn.ORCID 0000-0002-4084-5150
Rui ZhouDepartment of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. zhourui196@zju.edu.cn.ORCID 0000-0001-5373-6917

Funding

National Natural Science Foundation of China 32027802the Fundamental Research Funds for the Central Universities 226-2024-00059
6 · The paper itself

Abstract

purposeThis study aimed to investigate the role of [

methodsEighty-three patients with ILD who underwent LTx were retrospectively included in this study, among whom 43 received unilateral LTx and 40 received bilateral LTx. All the patients received [

resultsPost-operative ECMO time (p < 0.001), age (p = 0.006) and LDH (p = 0.015) were independent predictive factors for OS of unilateral LTx patients. In addition, LDH (p = 0.03) and gender (p = 0.03) were identified as independent factors for OS of bilateral LTx patients. Especially, we found that glucose metabolism (maximum standardized uptake values (SUVmax) of non-transplanted lung, SUVmax

conclusionThis study for the first time suggested that [

Indexed as

Fluorodeoxyglucose F18Lung Diseases, InterstitialLung TransplantationPositron Emission Tomography Computed TomographyAdultAgedFemaleHumansMaleMiddle AgedRadiopharmaceuticalsRetrospective StudiesSurvival AnalysisFluorodeoxyglucose F18Radiopharmaceuticals[18F]FDG PET/CTInterstitial lung diseasesLung transplantationSurvival prediction

Identifiers

PMID40366391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.